M&A Deal Summary |
|
|---|---|
| Date | 2022-05-19 |
| Target | Syrinx Bioanalytics |
| Sector | Life Science |
| Buyer(s) | Symeres |
| Deal Type | Add-on Acquisition |
SEARCH BY
Symeres is a mid-sized European Contract Research Organization for drug discovery and development needs. The company offers best-in-class solutions for drug discovery and drug development for small molecules and beyond. Their services span from preclinical hit finding all the way to the delivery of early clinical phase drug substance API. Symeres blends a deep scientific knowledge base with creativity and problem-solving skills to deliver the quality results that clients need. Symeres is based in Nijmegen, Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: Finland M&A | 1 of 1 |
| Year: 2022 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-26 |
Organix
Woburn, Massachusetts, United States Organix is specialized organic chemistry services provider with a focus on lipids. Organix was founded in 1986 and is based in Woburn, Massachusetts. |
Buy | - |
